9th Annual Biomarkers Congress
Seventh International Symposium on Melanoma and Other Cutaneous Malignancies
Jumeirah Essex House
160 Central Park South
New York City, New York
http://www.cancerlearning.com/index.cfm/fuseaction/conference.showFaculty/id/5/conference_id/282
Seventh International Symposium on Melanoma and Other Cutaneous Malignancies

Schedule of Presentations:

Friday, March 12, 2010
07:30:00 Registration and Continental Breakfast
08:00:00 Welcome and Introductions Sanjiv S. Agarwala
08:05:00 Session 1: Melanoma Prevention, Surveillance, and Diagnosis Allan Halpern
08:05:00 Presession Survey
08:10:00 Prevention and Risk: An Update
08:30:00 Current Diagnostic Tools Ashfaq A. Marghoob
08:50:00 New Technologies on the Horizon Allan Halpern
09:10:00 Panel Discussion
09:30:00 Break
09:35:00 Session 2: Clinical and Molecular Markers in Melanoma Sanjiv S. Agarwala
09:45:00 The Genetics of Melanoma Hensin Tsao
10:15:00 Moving Toward Personalized Therapy: Predictive Biomarkers for IFN, IL-2, DTIC/TMZ, and CTLA-4 Therapies
10:45:00 Postsession Survey/Panel Discussion
11:05:00 Break
11:10:00 Session 3: Surgery and Adjuvant Therapy Vernon K. Sondak
11:15:00 Presession Survey
11:20:00 Sentinel Lymph Node Biopsy: Status in 2010 Vernon K. Sondak
11:40:00 Adjuvant Therapy: Do We Have a New Standard? Alexander Eggermont
12:00:00 Break
12:05:00 Working Lunch
12:15:00 Interactive Diagnostic Workshop
13:30:00 Break
13:35:00 Session 4: Approaching Advanced Melanoma Sanjiv S. Agarwala
13:45:00 Presession Survey
13:50:00 A Phase II Trial of Chemoablation: An Update
14:10:00 Pulling the Apoptosis Trigger
14:30:00 Molecular Markers in Melanoma: Therapeutic Implications Mohammed Kashani-Sabet
14:50:00 Panel Discussion
15:15:00 Break
15:20:00 Session 5: Melanoma at Specific Anatomic Sites Allan Halpern
15:30:00 Targeted Therapies for Mucosal, Acral, and Uveal Melanoma: An Update Donald P. Lawrence
15:50:00 Targeting the Liver: Percutaneous Hepatic Perfusion/Intra-Arterial James , Pingpank
16:10:00 Managing Patients With Brain Metastases Wolfram Samlowski
16:30:00 Postsession Survey/Panel Discussion
16:50:00 Break
16:55:00 Session 6: Poster Presentations and Discussion (Non-CME)
17:00:00 Reception and Poster Presentations
17:45:00 Poster Discussion
18:00:00 Adjourn
Saturday, March 13, 2010
07:30:00 Continental Breakfast
08:00:00 Welcome and Introductions Sanjiv S. Agarwala
08:05:00 Presession Survey
08:05:00 Session 7: CTCL and Other Cutaneous Malignancies Francine Foss
08:10:00 Immune-Based Therapy in CTCL: When Should It Be Used? Francine Foss
08:30:00 Epigenetics and CTCL Therapy Steven Horwitz
08:50:00 Merkel Cell Carcinoma in 2010
09:10:00 Panel Discussion
09:30:00 Postsession Survey
09:35:00 Break
09:40:00 Session 8: Novel Agents: Update on Recent and Current Trials Keith Flaherty
09:50:00 The B-Raf Pathway in Melanoma: Is This the Therapeutic Target We Have Been Looking For? Keith Flaherty
10:10:00 Antiangiogenic Agents in Melanoma: Update on the BEAM Trial Steven O’Day
10:30:00 GM-CSF as Adjuvant Therapy: Update on E4697 David Lawson
10:50:00 Results of the AGENDA Trial: Does LDH Matter? Sanjiv S. Agarwala
11:10:00 Microtubule Inhibitors in Melanoma: Current Status Axel Hauschild
11:30:00 Is the Carboplatin/Paclitaxel Combination the New Standard in Metastatic Melanoma? Claus Garbe
11:50:00 Break
11:55:00 Working Lunch Sanjiv S. Agarwala
12:00:00 TBD
13:45:00 Break
13:50:00 Session 9: Enhancing Immune System Surveillance and Response Antoni Ribas
14:00:00 Presession Survey
14:05:00 Anti–CTLA-4 Antibodies and Dialing Down Tolerence Jedd D. Wolchok
14:25:00 Vaccines: Can We Turn the Tide?
14:45:00 Combining Chemotherapy With Immunotherapy: Does It Make Sense? Antoni Ribas
15:05:00 Postsession Survey/Panel Discussion
15:25:00 Presentation of Selected Oral Abstracts
16:00:00 Adjourn
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.